Skip to Content


Spaulding Clinical Research, LLC Expands Operations to Europe

April 28, 2017

Press Release:

28 April 2017 John Blank Joins Spaulding Clinical as Managing Director, European Operations as Global Capabilities Grow.

Mr. Blank has 20-plus years of experience in the contract and research and development industry on both sides of the Atlantic, managing and growing global teams.

In his role, Mr. Blank will engage with pharmaceutical and biotech companies in assessment of cardiac safety during the drug development process.  Spaulding is uniquely positioned as a leader in the field with an award winning clinical pharmacology unit and an innovative handheld ECG core lab solution.  Mr. Blank is joined by a European based consulting cardiologist of the highest caliber and reputation to provide medical and scientific expertise in cardiac safety assessment from protocol development to regulatory submission.


Read Full Press Release >>

Back to News

Ready to partner with Spaulding Clinical for your Phase I study?

Let’s Talk